Orthofix Medical
OFIX
ATLANTA, GA – – (Globe Newswire – August 22, 2024) – – A shareholder class action lawsuit has been filed against Orthofix Medical Inc. (“Orthofix” or “the Company”) (NASDAQ: OFIX). The lawsuit alleges that Orthofix’s management team was engaged in “repeated inappropriate and offensive conduct that violated multiple code of conduct requirements,” which was “inconsistent with the Company’s values and culture.” When the truth about the Company’s management team was revealed, the price of Orthofix common stock suffered sharp declines.
If you bought shares of Orthofix between October 11, 2022, and September 12, 2023, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/orthofix-medical/ to learn more.
The deadline to ask the court to be appointed lead plaintiff in the case is October 21, 2024.
Registration Deadline
Lead Plaintiff Deadline Has Passed
October 21, 2024